Mounjaro and the Contraceptive Pill: the Interaction Explained

Mounjaro slows the movement of food and fluid through the stomach, which can lower the absorption of medicines taken by mouth, including the contraceptive pill.
The additional contraception precaution applies for the first four weeks of Mounjaro use and for four weeks after each dose increase, it is a time-limited window, not a permanent requirement.
There is currently no equivalent evidence that semaglutide (Wegovy) reduces pill effectiveness in the same way; this interaction is specific to tirzepatide.
If you are planning to become pregnant, or are already pregnant or breastfeeding, Mounjaro is not recommended, stopping well in advance and discussing timing with your GP or prescriber matters.

Women taking Mounjaro alongside an oral contraceptive pill need to take an extra precaution: for the first four weeks of treatment, and for four weeks after every dose increase, a non-oral method of contraception — such as condoms — should be added. This is because Mounjaro slows gastric emptying, which can reduce how much of the pill is absorbed. The MHRA and NHS England's guidance on weight-management injections both flag this specifically for tirzepatide (the medicine in Mounjaro), and your prescriber will discuss it with you before treatment begins. Mounjaro is a prescription-only medicine; clinical assessment determines whether it is right for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to manage your contraception safely on Mounjaro, step by step

Step 1: Understand why the pill may be affected during the early weeks

Tirzepatide, the active ingredient in Mounjaro, is a dual GIP and GLP-1 receptor agonist. One of its actions is to slow gastric emptying, the rate at which the stomach passes its contents into the small intestine. For most purposes this is a feature, not a flaw; it is part of how the medicine reduces appetite. But it matters for oral medicines whose absorption depends on moving through the gut efficiently.

The contraceptive pill is absorbed through the intestinal wall. If gastric emptying is slowed, the window and extent of that absorption can change. NHS England's guidance is explicit on this point: women using oral contraceptives alongside Mounjaro should use an additional barrier method for four weeks from starting treatment and for four weeks after each dose step up. The NHS tirzepatide medicines page echoes this, noting that the pill may be less effective during these periods.

The precaution applies each time the dose increases, so at the 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg transitions as well as at the start. Outside those four-week windows, current evidence on whether Mounjaro affects the contraceptive pill does not indicate a sustained effect on pill absorption, but your prescriber is the right person to confirm what applies to your specific regimen.

Step 2: Plan your additional contraception before your first pen arrives

Practically, this means deciding which non-oral method you will use before you take your first Mounjaro dose. Condoms are the most straightforward choice for most women. A contraceptive patch, injection, implant, or hormonal IUS are all methods that bypass oral absorption entirely and are unaffected by gastric emptying, how Mounjaro interacts with the implant is a separate question worth reading if that is the route you prefer.

It is worth keeping a note of the date of each dose change. When your pen moves to the next strength, the four-week additional-contraception clock restarts from that injection day. Some women find it easiest to set a reminder on their phone alongside the weekly injection reminder, the same way you might put a sticky note on the fridge door next to where you store the pen.

If you take the pill for reasons beyond contraception (managing endometriosis or PCOS, for example) tell your prescriber this during your consultation. The interaction consideration does not disappear in that context, and your prescriber may want to involve your GP or specialist in the conversation.

Step 3: Know what the guidance says about pregnancy and stopping Mounjaro

Mounjaro is not recommended during pregnancy, while breastfeeding, or for anyone actively trying to conceive. This is a licensing position, not a precautionary preference: the medicine has not been studied in these groups, and the safety data needed to support its use simply do not exist. If you are planning a pregnancy, you should discuss stopping Mounjaro with your prescriber in good time, the MHRA advises a wash-out period before conception; your prescriber will guide you on what that looks like for you personally.

For a fuller picture of what the evidence says and where the gaps are, the fertility and pregnancy considerations page covers the topic in more detail. The short answer: use reliable contraception consistently throughout Mounjaro treatment, and plan any decision to stop in conversation with your clinical team rather than unilaterally.

More broadly, Mounjaro and contraception is a topic that spans several methods, the pill is the one that requires the most active management, but it is not the only one worth understanding before you start.

Step 4: Raise any uncertainty at your consultation, that is exactly what it is for

Questions about the contraceptive pill and Mounjaro are ones our prescribers hear regularly. A good consultation is the place to surface them, not an afterthought. When you consult with nume (with our clinical team) a GPhC-registered Independent Prescriber reads your answers personally the same day. They will ask about your current medicines, including contraception, and factor them into their decision.

If you are already on Mounjaro and have questions about a recent dose change, or want to revisit your contraceptive plan, our aftercare team is available seven days a week. You can also read the broader guidance on Mounjaro and oral contraceptives for more context on how this interaction is understood clinically.

Mounjaro is a prescription-only medicine. Whether it is clinically appropriate for you, and how to manage your contraception alongside it, is a decision made with a prescriber, not a one-size-fits-all protocol.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions